Form 4: Alzamend Neuro Director Receives Stock Grant
Insider Transaction (Form 4)
Milton C Ault Iii, a Director of Alzamend Neuro, Inc., received 7,500 shares of common stock on July 31, 2026.
Summary
- Grant/award: acquired 7,500 Series D Convertible Preferred Stock at $1,000.00 ($7,500,000) on July 31, 2026; holds 7,500 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Milton C Ault Iii — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Series D Convertible Preferred Stock | 7,500 | $1.0K | $7.5M | 7,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (7,500 shares) |
Keywords
insider transaction, Form 4, ALZN, Alzamend Neuro, Inc., neutral, Milton C Ault Iii
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.